by Cassie Arnold | Feb 9, 2021 | Biotech Finance, COVID, Deal making, Investment
If you had an inkling that more money went to vaccine and diagnostic companies in 2020, you were right. Diagnostics and vaccines have long been the red-headed stepchildren of life sciences investments. Detecting and treating life threatening diseases is the...
by Cassie Arnold | Jan 28, 2021 | Biotech Finance, Deal making, Digital Health, Digital Therapeutics, Investment
After starting off 2020 with a 35 percent drop in the number of deals from the previous quarter, digital therapeutic deal-making steadily climbed over the course of 2020 to total 71 deals for the year. With 25 deals in the fourth quarter of 2020, the index was up 44...
by Cassie Arnold | Nov 10, 2020 | Biotech Finance, Deal making, Digital Health, Digital Therapeutic
Tired from a long week of parsing electoral college votes? How about focusing on digital therapeutic deals for a change of pace? The third quarter brought a record number of digital therapeutic deals with a total of 19. That’s up from 16 in the previous quarter. The...
by Cassie Arnold | Aug 13, 2020 | Advertising, Branding, Communications, Persuasion
With the selection of Kamala Harris as Joe Biden’s running mate, it was time for Biden campaign (Biden/Harris that is) to role out a new brand. A while back I took a look at the logos of the various Democratic candidates and noted that many of the logos...
by Cassie Arnold | Aug 10, 2020 | Communications, Persuasion
As a communication project, the campaign to spread the word about mask wearing during the pandemic has been an example of how to do everything wrong. Let’s put aside the early missteps on the subject as well as the political overtones it has taken on. Let’s just...
